Condition: Barrett Esophagus · Esophageal Adenocarcinoma · Sponsor: Mayo Clinic
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
This description comes directly from the study's public registry record.
Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic Arizona | Scottsdale, Arizona, United States | Completed |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Completed |
| Mayo Clinic Health Systems - Austin | Austin, Minnesota, United States | Recruiting |
| Mayo Clinic Health Systems - Mankato | Mankato, Minnesota, United States | Completed |
| Mayo Clinic Rochester | Rochester, Minnesota, United States | Recruiting |
| Northwell Health | New Hyde Park, New York, United States | Completed |
| Baylor Scott & White Research Institute | Dallas, Texas, United States | Completed |
| Mayo Clinic Health System-Eau Claire | Eau Claire, Wisconsin, United States | Recruiting |
| Mayo Clinic Health System-Franciscan Healthcare | La Crosse, Wisconsin, United States | Withdrawn |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03961945